CXCL10 and neoplasm: IP-10 (CXCL10) has also been demonstrated to induce cell proliferation, migration, and epithelial to mesenchymal transition in MCF-7 and MDA-MB-231 breast cancer cell lines [109], which would contribute to a more aggressive profile supportive of greater tumor volume in BCW0 mice.